![August 25, 2011 - University of South Alabama Health System](http://s1.studyres.com/store/data/008605621_1-6cf51c979797e460e312cd519813c2ce-300x300.png)
August 25, 2011 - University of South Alabama Health System
... – High insulin but low C-peptide: got an insulin shot – High insulin and high C-peptide: has an insulin tumor or ate grandma’s sulfonylurea medicine – (Insulin turns off ketones, so a positive urine test for ketones means that insulin levels are not too high) – Proinsulin: Tells you nothing – Cortis ...
... – High insulin but low C-peptide: got an insulin shot – High insulin and high C-peptide: has an insulin tumor or ate grandma’s sulfonylurea medicine – (Insulin turns off ketones, so a positive urine test for ketones means that insulin levels are not too high) – Proinsulin: Tells you nothing – Cortis ...
diseases of the endocrine system
... ↑ lipolysis in adipose tissue → fatty acids →ketone bodies →ketoacidosis →coma (insulin normally inhibits lipolysis) ↑ hepatic gluconeogenesis (in spite of high plasma glucose levels) (insulin normally inhibits gluconeogenesis) ...
... ↑ lipolysis in adipose tissue → fatty acids →ketone bodies →ketoacidosis →coma (insulin normally inhibits lipolysis) ↑ hepatic gluconeogenesis (in spite of high plasma glucose levels) (insulin normally inhibits gluconeogenesis) ...
Essentials of Anatomy and Physiology, 5e (Martini
... What are the inner and outer layers of the suprarenal gland called? Inadequate insulin production would result in what disease? Which hormones cause the increased metabolic activity associated with the fight or flight response? The interstitial cells of the testes respond to luteinizing hormone by p ...
... What are the inner and outer layers of the suprarenal gland called? Inadequate insulin production would result in what disease? Which hormones cause the increased metabolic activity associated with the fight or flight response? The interstitial cells of the testes respond to luteinizing hormone by p ...
Glucose Regulation, Liver and Pancreas
... Liver receives blood from intestines (don’t forget hepatic portal system After meal, in response to insulin from pancreas, glucose stored as complex carbohydrate--glycogen--in liver Between meals, in response to glucagon from pancreas, glucose is released Pancreas releases insulin when sugar levels ...
... Liver receives blood from intestines (don’t forget hepatic portal system After meal, in response to insulin from pancreas, glucose stored as complex carbohydrate--glycogen--in liver Between meals, in response to glucagon from pancreas, glucose is released Pancreas releases insulin when sugar levels ...
Cushing`s Disease in Horses The condition known as Cushing`s
... which dexamethasone (an exogenous steroid that mimics cortisol) is administered, and then ACTH is measured 12 or 24 hours later. This test measures the body’s ability to respond to negative feedback, in other words, to down regulate its production of stress hormones in response to finding that level ...
... which dexamethasone (an exogenous steroid that mimics cortisol) is administered, and then ACTH is measured 12 or 24 hours later. This test measures the body’s ability to respond to negative feedback, in other words, to down regulate its production of stress hormones in response to finding that level ...
Text Version
... ACTH stimulation test (no response in primary) Serum potassium (high if associated deficiency of aldosterone) Serum glucose (low) ...
... ACTH stimulation test (no response in primary) Serum potassium (high if associated deficiency of aldosterone) Serum glucose (low) ...
Insulin Secretory and Insulin Resistance Defects in Type 2 Diabetes
... overt diabetes. Specifically, the study showed that while most patients with type 2 DM had some degree of insulin resistance, there were patients with a confirmed diagnosis of diabetes who had no evidence of insulin resistance. These individuals remained normoglycemic by compensating for the reducti ...
... overt diabetes. Specifically, the study showed that while most patients with type 2 DM had some degree of insulin resistance, there were patients with a confirmed diagnosis of diabetes who had no evidence of insulin resistance. These individuals remained normoglycemic by compensating for the reducti ...
10mm Insulin Pump Drive
... 10mm Insulin Pump Drive Introduction: Johnson Medtech provides high performance and reliable miniature motion subsystems for various types of insulin pumps. Planetary Gearbox Drive with integrated sensor system provides high dosing accuracy within a small volume. The brushless DC motor configuration ...
... 10mm Insulin Pump Drive Introduction: Johnson Medtech provides high performance and reliable miniature motion subsystems for various types of insulin pumps. Planetary Gearbox Drive with integrated sensor system provides high dosing accuracy within a small volume. The brushless DC motor configuration ...
Diabetes Packet - Vernon Township School District
... ☐ When student exhibits symptoms of hyperglycemia ☐ When a student exhibits symptoms of hypoglycemia ☐ Other ...
... ☐ When student exhibits symptoms of hyperglycemia ☐ When a student exhibits symptoms of hypoglycemia ☐ Other ...
Sickle Cell Disease
... Alters diabetic management Dosage requirements may increase, decrease, or remain unchanged depending on the severity of the illness & the child’s appetite Rapid-acting insulin used to manage hyperglycemia associated with illness Monitor fluids, may require extra oral fluids while ill ...
... Alters diabetic management Dosage requirements may increase, decrease, or remain unchanged depending on the severity of the illness & the child’s appetite Rapid-acting insulin used to manage hyperglycemia associated with illness Monitor fluids, may require extra oral fluids while ill ...
BRS Physiology Cases and Problems 2nd Edition
... because, as blood pooled in the veins of the legs, venous return and cardiac output were compromised further. 6. Insulin is a protein; therefore, it must be administered parenterally (i.e., by routes other than the gastrointestinal tract). If given orally, it would be digested by intestinal peptidas ...
... because, as blood pooled in the veins of the legs, venous return and cardiac output were compromised further. 6. Insulin is a protein; therefore, it must be administered parenterally (i.e., by routes other than the gastrointestinal tract). If given orally, it would be digested by intestinal peptidas ...
Diabetes-Update-2009.3
... • May present in Diabetic Ketoacidosis • Obesity is NOT protective • Usually childhood, but ANY age ...
... • May present in Diabetic Ketoacidosis • Obesity is NOT protective • Usually childhood, but ANY age ...
Fact Sheet Series - Job Accommodation Network
... Diabetes Mellitus is a disease that occurs when the body is not able to use sugar as it should. The body needs sugar for growth and energy for daily activities, and it gets sugar when it changes food into glucose (a form of sugar). A hormone called insulin is needed for the glucose to be used by the ...
... Diabetes Mellitus is a disease that occurs when the body is not able to use sugar as it should. The body needs sugar for growth and energy for daily activities, and it gets sugar when it changes food into glucose (a form of sugar). A hormone called insulin is needed for the glucose to be used by the ...
DKA Precipitated by Iatrogenic Thyrotoxicosis
... 28 year old compliant man with a history of type I diabetes mellitus and primary hypothyroidism, presented to the ER for a two day history of fatigue, nausea, vomiting and abdominal pain. On physical exam, patient was drowsy with dry skin and normal temperature. Kussmaul respirations were noted and ...
... 28 year old compliant man with a history of type I diabetes mellitus and primary hypothyroidism, presented to the ER for a two day history of fatigue, nausea, vomiting and abdominal pain. On physical exam, patient was drowsy with dry skin and normal temperature. Kussmaul respirations were noted and ...
DPP-4 Inhibitor - Canadian Diabetes Guidelines
... • Take Linagliptin 5 mg in single or divided doses with combination product • Take Saxagliptin 2.5 mg to 5 mg in single or divided doses with combination product • Take Sitagliptin 25 mg to 100 mg in single or divided doses with combination product ...
... • Take Linagliptin 5 mg in single or divided doses with combination product • Take Saxagliptin 2.5 mg to 5 mg in single or divided doses with combination product • Take Sitagliptin 25 mg to 100 mg in single or divided doses with combination product ...
Endocrine Part 2 Powerpoint
... • Erythropoietin (EPO) is a hormone released by the kidneys in response to low blood oxygen – Increases production of red blood cells ...
... • Erythropoietin (EPO) is a hormone released by the kidneys in response to low blood oxygen – Increases production of red blood cells ...
Laboratory Values
... diabetes (Type I or II) as a result of loss of pancreatic insulin production or systemic cellular sensitivity leading to a build up of serum glucose. There is an inability of cells to take up glucose and a resulting “cellular starvation” leading to alternate metabolic pathways (ketoacidosis). Treatm ...
... diabetes (Type I or II) as a result of loss of pancreatic insulin production or systemic cellular sensitivity leading to a build up of serum glucose. There is an inability of cells to take up glucose and a resulting “cellular starvation” leading to alternate metabolic pathways (ketoacidosis). Treatm ...
Sickle Cell Disease
... Followed by a complex CHO & Protein Slice of bread or cracker with peanut butter Glucagon SQ for severe hypoglycemia (may cause vomiting, prevent aspiration) ...
... Followed by a complex CHO & Protein Slice of bread or cracker with peanut butter Glucagon SQ for severe hypoglycemia (may cause vomiting, prevent aspiration) ...
Sickle Cell Disease
... Illness alters diabetic management • Dosage requirements may increase, decrease, or remain unchanged depending on the severity of the illness & the child’s appetite • Rapid-acting insulin only is used to manage hyperglycemia associated with illness • Monitor fluids, may require extra oral fluids wh ...
... Illness alters diabetic management • Dosage requirements may increase, decrease, or remain unchanged depending on the severity of the illness & the child’s appetite • Rapid-acting insulin only is used to manage hyperglycemia associated with illness • Monitor fluids, may require extra oral fluids wh ...
Endocrine disorders
... - Modest weight gain due to decreased metabolic rate and accumulation of fluid - Marked obesity is not characteristic - Ascites is rare ...
... - Modest weight gain due to decreased metabolic rate and accumulation of fluid - Marked obesity is not characteristic - Ascites is rare ...
5. Pancreas: Glucagon
... • non-insulin-dependent (NIDDM; formerly mature-onset diabetes) • usually starts after age 40 • insulin levels are normal or elevated, but peripheral tissue become less sensitive to it • 25-30% of Americans carry gene that predisposes them to NIDDM, more likely in over-weight people (~90% of cases) ...
... • non-insulin-dependent (NIDDM; formerly mature-onset diabetes) • usually starts after age 40 • insulin levels are normal or elevated, but peripheral tissue become less sensitive to it • 25-30% of Americans carry gene that predisposes them to NIDDM, more likely in over-weight people (~90% of cases) ...
Diseases_2016
... •Diabetes involves insulin (IN suh lin), a hormone produced by the pancreas that stimulates body cells to take up and use blood sugar. •If not controlled, diabetes can be life-threatening. •People with diabetes are also at risk for •heart disease •stroke •kidney disease •blindness •infections requir ...
... •Diabetes involves insulin (IN suh lin), a hormone produced by the pancreas that stimulates body cells to take up and use blood sugar. •If not controlled, diabetes can be life-threatening. •People with diabetes are also at risk for •heart disease •stroke •kidney disease •blindness •infections requir ...
My Pediatric Endocrine Powerpoint
... Fat breaks down into fatty acids and the glycerol in fat Is converted to ketones by the liver. Excess ketones are eliminated in the urine (ketonuria) Or by the lungs (causing acetone or fruity breath) Ketones are strong acids in the blood (ketoacidosis) ...
... Fat breaks down into fatty acids and the glycerol in fat Is converted to ketones by the liver. Excess ketones are eliminated in the urine (ketonuria) Or by the lungs (causing acetone or fruity breath) Ketones are strong acids in the blood (ketoacidosis) ...
B2.7 Homeostasis
... so that more blood flows through the capillaries and more heat is lost Sweat glands release more sweat which cools the body as it evaporates ...
... so that more blood flows through the capillaries and more heat is lost Sweat glands release more sweat which cools the body as it evaporates ...
Diabetic ketoacidosis
![](https://commons.wikimedia.org/wiki/Special:FilePath/Infuuszakjes.jpg?width=300)
Diabetic ketoacidosis (DKA) is a potentially life-threatening complication in patients with diabetes mellitus. It happens predominantly in those with type 1 diabetes, but it can occur in those with type 2 diabetes under certain circumstances. DKA results from a shortage of insulin; in response the body switches to burning fatty acids and producing acidic ketone bodies that cause most of the symptoms and complications.DKA may be the first symptom of previously undiagnosed diabetes, but it may also occur in people known to have diabetes as a result of a variety of causes, such as intercurrent illness or poor compliance with insulin therapy. Vomiting, dehydration, deep gasping breathing, confusion and occasionally coma are typical symptoms. DKA is diagnosed with blood and urine tests; it is distinguished from other, rarer forms of ketoacidosis by the presence of high blood sugar levels. Treatment involves intravenous fluids to correct dehydration, insulin to suppress the production of ketone bodies, treatment for any underlying causes such as infections, and close observation to prevent and identify complications.DKA is a medical emergency, and without treatment it can lead to death. DKA was first described in 1886; until the introduction of insulin therapy in the 1920s, it was almost universally fatal. It now carries a mortality of less than 1% with adequate and timely treatment.